$MYGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MYRIAD GENETICS INC. Get notifications about new insider transactions in MYRIAD GENETICS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 23 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 39.37 | 3,609 | 142,088 | 39,743 | 43.4 K to 39.7 K (-8.32 %) |
Jun 08 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 21.29 | 3,609 | 76,836 | 43,352 | 39.7 K to 43.4 K (+9.08 %) |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 24.39 | 1,189 | 29,000 | 0 | |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Option Exercise | M | 24.39 | 28,811 | 702,700 | 1,189 | |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 39.80 | 1,189 | 47,322 | 27,243 | 28.4 K to 27.2 K (-4.18 %) |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 24.39 | 1,189 | 29,000 | 28,432 | 27.2 K to 28.4 K (+4.36 %) |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 39.68 | 28,811 | 1,143,267 | 27,243 | 56.1 K to 27.2 K (-51.40 %) |
Jun 07 2018 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Buy | M | 24.39 | 28,811 | 702,700 | 56,054 | 27.2 K to 56.1 K (+105.76 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 24.40 | 30,000 | 732,000 | 0 | |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 0 | |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 21.29 | 1,227 | 26,123 | 20,369 | |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 21.29 | 8,404 | 178,921 | 21,596 | |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 39.90 | 1,227 | 48,957 | 39,743 | 41 K to 39.7 K (-2.99 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 21.29 | 1,227 | 26,123 | 40,970 | 39.7 K to 41 K (+3.09 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 39.90 | 8,404 | 335,320 | 39,743 | 48.1 K to 39.7 K (-17.45 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 21.29 | 8,404 | 178,921 | 48,147 | 39.7 K to 48.1 K (+21.15 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 39.90 | 10,000 | 399,000 | 39,743 | 49.7 K to 39.7 K (-20.10 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 24.39 | 10,000 | 243,900 | 49,743 | 39.7 K to 49.7 K (+25.16 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 38.90 | 30,000 | 1,167,000 | 39,743 | 69.7 K to 39.7 K (-43.02 %) |
Jun 05 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 24.40 | 30,000 | 732,000 | 69,743 | 39.7 K to 69.7 K (+75.48 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 22.93 | 90,000 | 2,063,700 | 0 | |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 38.00 | 90,000 | 3,420,000 | 332,175 | 422.2 K to 332.2 K (-21.32 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 22.93 | 90,000 | 2,063,700 | 422,175 | 332.2 K to 422.2 K (+27.09 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 30.34 | 33,139 | 1,005,437 | 33,000 | |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 30.34 | 33,139 | 1,005,437 | 33,000 | |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 38.00 | 33,139 | 1,259,282 | 123,769 | 156.9 K to 123.8 K (-21.12 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 38.00 | 33,139 | 1,259,282 | 123,769 | 156.9 K to 123.8 K (-21.12 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 30.34 | 33,139 | 1,005,437 | 156,908 | 123.8 K to 156.9 K (+26.77 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 30.34 | 33,139 | 1,005,437 | 156,908 | 123.8 K to 156.9 K (+26.77 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 10,000 | |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 37.92 | 10,000 | 379,245 | 39,743 | 49.7 K to 39.7 K (-20.10 %) |
Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 24.39 | 10,000 | 243,900 | 49,743 | 39.7 K to 49.7 K (+25.16 %) |
May 21 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Option Exercise | M | 24.39 | 10,000 | 243,900 | 20,000 | |
May 21 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Sell | S | 35.90 | 10,000 | 359,000 | 39,743 | 49.7 K to 39.7 K (-20.10 %) |
May 21 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Buy | M | 24.39 | 10,000 | 243,900 | 49,743 | 39.7 K to 49.7 K (+25.16 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 30,000 | 584,100 | 27,432 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 4,445 | 80,010 | 0 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.03 | 4,445 | 173,488 | 121,968 | 126.4 K to 122 K (-3.52 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 4,445 | 80,010 | 126,413 | 122 K to 126.4 K (+3.64 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.77 | 30,000 | 1,193,100 | 121,968 | 152 K to 122 K (-19.74 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 30,000 | 584,100 | 151,968 | 122 K to 152 K (+24.60 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 30.12 | 37,654 | 1,134,138 | 0 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 26.49 | 3,775 | 100,000 | 0 | |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 26.49 | 3,775 | 100,000 | 123,769 | 120 K to 123.8 K (+3.15 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 40.25 | 37,654 | 1,515,611 | 119,994 | 157.6 K to 120 K (-23.88 %) |
Jan 22 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 30.12 | 37,654 | 1,134,138 | 157,648 | 120 K to 157.6 K (+31.38 %) |
Jan 16 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 36.25 | 13,759 | 498,764 | 119,994 | 133.8 K to 120 K (-10.29 %) |
Jan 16 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 3,000 | 0 | 133,753 | 136.8 K to 133.8 K (-2.19 %) |
Jan 16 2018 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 1,500 | 0 | 136,385 | 137.9 K to 136.4 K (-1.09 %) |
Jan 03 2018 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 34.91 | 3,621 | 126,409 | 142,551 | 146.2 K to 142.6 K (-2.48 %) |
Dec 15 2017 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 33.19 | 7,500 | 248,925 | 27,243 | 34.7 K to 27.2 K (-21.59 %) |
Dec 12 2017 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Sell | S | 33.50 | 6,000 | 201,000 | 33,743 | 39.7 K to 33.7 K (-15.10 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 7,219 | 0 | 39,743 | 32.5 K to 39.7 K (+22.20 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Grant | A | 0.00 | 7,219 | 0 | 34,743 | 27.5 K to 34.7 K (+26.23 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 7,219 | 0 | 49,743 | 42.5 K to 49.7 K (+16.98 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 7,219 | 0 | 39,743 | 32.5 K to 39.7 K (+22.20 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 7,219 | 0 | 39,743 | 32.5 K to 39.7 K (+22.20 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 7,219 | 0 | 30,743 | 23.5 K to 30.7 K (+30.69 %) |
Oct 17 2017 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 35.84 | 3,522 | 126,228 | 109,988 | 113.5 K to 110 K (-3.10 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | D | 36.18 | 1,937 | 70,081 | 79,800 | 81.7 K to 79.8 K (-2.37 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | D | 36.18 | 7,043 | 254,816 | 81,737 | 88.8 K to 81.7 K (-7.93 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 36.18 | 5,218 | 188,787 | 146,172 | 151.4 K to 146.2 K (-3.45 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 36.18 | 6,472 | 234,157 | 151,390 | 157.9 K to 151.4 K (-4.10 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 36.18 | 3,522 | 127,426 | 121,917 | 125.4 K to 121.9 K (-2.81 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 36.18 | 4,050 | 146,529 | 125,439 | 129.5 K to 125.4 K (-3.13 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 36.18 | 800 | 28,944 | 49,200 | 50 K to 49.2 K (-1.60 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 36.18 | 9,238 | 334,231 | 332,175 | 341.4 K to 332.2 K (-2.71 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 36.18 | 19,367 | 700,698 | 341,413 | 360.8 K to 341.4 K (-5.37 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 36.18 | 5,599 | 202,572 | 113,510 | 119.1 K to 113.5 K (-4.70 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 36.18 | 7,043 | 254,816 | 119,109 | 126.2 K to 119.1 K (-5.58 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | D | 36.18 | 5,291 | 191,428 | 137,885 | 143.2 K to 137.9 K (-3.70 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | D | 36.18 | 5,869 | 212,340 | 143,176 | 149 K to 143.2 K (-3.94 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 36.18 | 5,459 | 197,507 | 138,809 | 144.3 K to 138.8 K (-3.78 %) |
Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 36.18 | 5,869 | 212,340 | 144,268 | 150.1 K to 144.3 K (-3.91 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 33.05 | 5,400 | 178,470 | 129,489 | 134.9 K to 129.5 K (-4.00 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | D | 33.05 | 1,937 | 64,018 | 88,780 | 90.7 K to 88.8 K (-2.14 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Sell | D | 33.05 | 2,188 | 72,313 | 111,877 | 114.1 K to 111.9 K (-1.92 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 33.05 | 6,897 | 227,946 | 150,137 | 157 K to 150.1 K (-4.39 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | D | 33.05 | 6,684 | 220,906 | 149,045 | 155.7 K to 149 K (-4.29 %) |
Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 33.05 | 11,671 | 385,727 | 360,780 | 372.5 K to 360.8 K (-3.13 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 30,000 | 0 | 134,889 | 104.9 K to 134.9 K (+28.60 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 40,000 | 0 | 50,000 | 10 K to 50 K (+400.00 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Grant | A | 0.00 | 50,000 | 0 | 157,034 | 107 K to 157 K (+46.71 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 40,000 | 0 | 157,862 | 117.9 K to 157.9 K (+33.94 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Grant | A | 0.00 | 60,000 | 0 | 90,717 | 30.7 K to 90.7 K (+195.33 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Grant | A | 0.00 | 30,000 | 0 | 114,065 | 84.1 K to 114.1 K (+35.69 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 60,000 | 0 | 126,152 | 66.2 K to 126.2 K (+90.70 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Grant | A | 0.00 | 50,000 | 0 | 155,729 | 105.7 K to 155.7 K (+47.29 %) |
Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 165,000 | 0 | 372,451 | 207.5 K to 372.5 K (+79.54 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 0 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 10,000 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 16.46 | 10,000 | 164,600 | 20,000 | |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.30 | 10,000 | 302,981 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.30 | 10,000 | 303,003 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 30.31 | 10,000 | 303,056 | 42,524 | 52.5 K to 42.5 K (-19.04 %) |
Sep 05 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 16.46 | 10,000 | 164,600 | 52,524 | 42.5 K to 52.5 K (+23.52 %) |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.57 | 400 | 7,429 | 42,524 | 42.1 K to 42.5 K (+0.95 %) |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.58 | 3,600 | 66,888 | 42,124 | 38.5 K to 42.1 K (+9.34 %) |
Feb 23 2017 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | P | 18.81 | 2,000 | 37,613 | 38,524 | 36.5 K to 38.5 K (+5.48 %) |
Jan 04 2017 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 16.93 | 2,631 | 44,543 | 116,360 | 119 K to 116.4 K (-2.21 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 15,024 | 0 | 23,524 | 8.5 K to 23.5 K (+176.75 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 15,024 | 0 | 32,524 | 17.5 K to 32.5 K (+85.85 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 15,024 | 0 | 32,524 | 17.5 K to 32.5 K (+85.85 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Grant | A | 0.00 | 15,024 | 0 | 27,524 | 12.5 K to 27.5 K (+120.19 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 15,024 | 0 | 36,524 | 21.5 K to 36.5 K (+69.88 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 15,024 | 0 | 32,524 | 17.5 K to 32.5 K (+85.85 %) |
Oct 17 2016 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 19.31 | 3,522 | 68,010 | 66,152 | 69.7 K to 66.2 K (-5.05 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | D | 20.58 | 1,937 | 39,863 | 29,213 | 31.2 K to 29.2 K (-6.22 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Sell | D | 20.58 | 4,661 | 95,923 | 118,991 | 123.7 K to 119 K (-3.77 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 20.58 | 5,459 | 112,346 | 107,034 | 112.5 K to 107 K (-4.85 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Sell | D | 20.58 | 1,641 | 33,772 | 82,891 | 84.5 K to 82.9 K (-1.94 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 20.58 | 5,599 | 115,227 | 69,674 | 75.3 K to 69.7 K (-7.44 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Wenstrup Richard | Chief Medical Offic ... | Sell | D | 20.58 | 931 | 19,160 | 50,207 | 51.1 K to 50.2 K (-1.82 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | D | 20.58 | 3,646 | 75,035 | 110,134 | 113.8 K to 110.1 K (-3.20 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 20.58 | 4,050 | 83,349 | 103,449 | 107.5 K to 103.4 K (-3.77 %) |
Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 20.58 | 9,238 | 190,118 | 207,451 | 216.7 K to 207.5 K (-4.26 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Sell | D | 20.92 | 2,188 | 45,773 | 84,532 | 86.7 K to 84.5 K (-2.52 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | Wenstrup Richard | Chief Medical Offic ... | Sell | D | 20.92 | 931 | 19,477 | 51,138 | 52.1 K to 51.1 K (-1.79 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | D | 20.92 | 3,721 | 77,843 | 107,499 | 111.2 K to 107.5 K (-3.35 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | D | 20.92 | 1,335 | 27,928 | 31,150 | 32.5 K to 31.2 K (-4.11 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 20.92 | 4,752 | 99,412 | 112,493 | 117.2 K to 112.5 K (-4.05 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | D | 20.92 | 4,606 | 96,358 | 113,780 | 118.4 K to 113.8 K (-3.89 %) |
Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 20.92 | 8,042 | 168,239 | 216,689 | 224.7 K to 216.7 K (-3.58 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Drosos Virginia | President Assurex H ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Grant | A | 0.00 | 30,000 | 0 | 86,720 | 56.7 K to 86.7 K (+52.89 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Wenstrup Richard | Chief Medical Offic ... | Grant | A | 0.00 | 30,000 | 0 | 52,069 | 22.1 K to 52.1 K (+135.94 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 40,000 | 0 | 126,220 | 86.2 K to 126.2 K (+46.39 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 49,608 | 0 | 86,220 | 36.6 K to 86.2 K (+135.50 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 30,000 | 0 | 111,220 | 81.2 K to 111.2 K (+36.94 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Grant | A | 0.00 | 46,508 | 0 | 117,245 | 70.7 K to 117.2 K (+65.75 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Grant | A | 0.00 | 45,077 | 0 | 118,386 | 73.3 K to 118.4 K (+61.49 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 47,700 | 0 | 75,273 | 27.6 K to 75.3 K (+173.00 %) |
Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 78,705 | 0 | 224,731 | 146 K to 224.7 K (+53.90 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 10.60 | 2,007 | 21,274 | 0 | |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Option Exercise | M | 10.60 | 27,993 | 296,726 | 2,007 | |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 20.21 | 2,007 | 40,568 | 21,500 | 23.5 K to 21.5 K (-8.54 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 10.60 | 2,007 | 21,274 | 23,507 | 21.5 K to 23.5 K (+9.33 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Sell | S | 20.51 | 27,993 | 574,248 | 21,500 | 49.5 K to 21.5 K (-56.56 %) |
Sep 13 2016 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Buy | M | 10.60 | 27,993 | 296,726 | 49,493 | 21.5 K to 49.5 K (+130.20 %) |
Aug 19 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | P | 21.24 | 10,000 | 212,400 | 146,026 | 136 K to 146 K (+7.35 %) |
Aug 15 2016 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Buy | P | 21.49 | 1,000 | 21,490 | 56,720 | 55.7 K to 56.7 K (+1.79 %) |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Option Exercise | M | 19.47 | 5,449 | 106,092 | 0 | |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Option Exercise | M | 18.00 | 11,000 | 198,000 | 0 | |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | S | 30.86 | 2,188 | 67,530 | 32,485 | 34.7 K to 32.5 K (-6.31 %) |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | S | 30.87 | 11,000 | 339,614 | 34,673 | 45.7 K to 34.7 K (-24.08 %) |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Buy | M | 18.00 | 11,000 | 198,000 | 45,673 | 34.7 K to 45.7 K (+31.72 %) |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Sell | S | 30.88 | 5,449 | 168,241 | 34,673 | 40.1 K to 34.7 K (-13.58 %) |
Jun 22 2016 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Buy | M | 19.47 | 5,449 | 106,092 | 40,122 | 34.7 K to 40.1 K (+15.72 %) |